The two largest health insurers in Massachusetts are effectively telling the drug companies that they may seek a rapidly ...

Insurers are cutting coverage, citing costs. But there’s seldom any discussion of the return on investment from these drugs ...

As the use of GLP-1 medications such as Ozempic, Wegovy and Mounjaro becomes more widespread for weight loss, a growing concern is the unintended loss of muscle mass that often accompanies rapid fat ...

GLP-1 drugs like Ozempic® and Zepbound® have gained significant attention for treating both diabetes and assisting with weight loss.

The country’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, the UK’s official system for ...

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

Health insurance companies, including CVS Caremark, are altering coverage for GLP-1 weight loss medications like Zepbound, ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...

GLP-1 weight loss patches are everywhere but do they actually work as these trendy patches promise Ozempic-like results ...

MariTide, a new drug from Amgen, helped some people with obesity lose up to 20% of their body weight. In a phase 2 trial, a new GLP-1 drug helped people lose up to 20% of their body weight over a year ...

Lizzo has shown off her dramatic weight loss in a new Instagram before-and-after post - and fans are all saying the same ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...